Immunome IMNM
NASDAQ IMNM
$21.25 +0.36 (+1.70%)
As of: Oct 2, 2026 · 10:30 AM EDT

Immunome (IMNM) Invested Capital (2020 - 2021)

Updated

Immunome (IMNM) recorded Invested Capital of $38.38 million in Q1 2021, down 8.3% from the prior quarter.

Analysis

Immunome (IMNM) Invested Capital (2020 - 2021) Analysis & Trends

For FY2020, Immunome reported Invested Capital of $41.85 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Immunome 2.44 Bn 410.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 38.38 Mn
Dec 31, 2020 41.85 Mn
Sep 30, 2020 -48.59 Mn
API Access

Immunome Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=IMNM&period=max&api_key=YOUR_API_KEY